Iagaru A - Search Results

1

Treatment and outcomes in classic Hodgkin lymphoma post-transplant lymphoproliferative disorder in children.

Twist CJ, Hiniker SM, Gratzinger D, Gutkin PM, Merriott DJ, Iagaru A, Link MP, Donaldson SS. Twist CJ, et al. Among authors: iagaru a. Pediatr Blood Cancer. 2019 Aug;66(8):e27803. doi: 10.1002/pbc.27803. Epub 2019 May 7. Pediatr Blood Cancer. 2019. PMID: 31062898

2

(18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.

Takehana CS, Twist CJ, Mosci C, Quon A, Mittra E, Iagaru A. Takehana CS, et al. Among authors: iagaru a. Nucl Med Commun. 2014 Mar;35(3):276-81. doi: 10.1097/MNM.0000000000000050. Nucl Med Commun. 2014. PMID: 24296883

3

Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.

Mahapatra S, Chin CC, Iagaru A, Heerema-McKenney A, Twist CJ. Mahapatra S, et al. Among authors: iagaru a. Pediatr Blood Cancer. 2014 Nov;61(11):2107-9. doi: 10.1002/pbc.25129. Epub 2014 Jul 25. Pediatr Blood Cancer. 2014. PMID: 25066638

4

¹⁸F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD).

Song H, Guja KE, Iagaru A. Song H, et al. Among authors: iagaru a. Semin Nucl Med. 2021 Jul;51(4):392-403. doi: 10.1053/j.semnuclmed.2020.12.009. Epub 2021 Jan 15. Semin Nucl Med. 2021. PMID: 33455722 Review.

5

90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging.

Iagaru A, Gambhir SS, Goris ML. Iagaru A, et al. J Nucl Med. 2008 Nov;49(11):1809-12. doi: 10.2967/jnumed.108.052928. Epub 2008 Oct 16. J Nucl Med. 2008. PMID: 18927323 Free article.

6

(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?

Iagaru A, Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS. Iagaru A, et al. Hell J Nucl Med. 2008 Sep-Dec;11(3):153-6. Hell J Nucl Med. 2008. PMID: 19081857

7

131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.

Iagaru A, Mittra ES, Ganjoo K, Knox SJ, Goris ML. Iagaru A, et al. Mol Imaging Biol. 2010 Apr;12(2):198-203. doi: 10.1007/s11307-009-0245-9. Epub 2009 Jun 20. Mol Imaging Biol. 2010. PMID: 19543946

8

Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

Sartor O, Vogelzang NJ, Sweeney C, Fernandez DC, Almeida F, Iagaru A, Brown A Jr, Smith MR, Agrawal M, Dicker AP, Garcia JA, Lutzky J, Wong YN, Petrenciuc O, Gratt J, Shore ND, Morris MJ; U.S. Expanded Access Program Investigators. Sartor O, et al. Among authors: iagaru a. Oncologist. 2018 Feb;23(2):193-202. doi: 10.1634/theoncologist.2017-0413. Epub 2017 Nov 28. Oncologist. 2018. PMID: 29183960 Free PMC article. Clinical Trial.

9

Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.

Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, Witteles R. Ning N, et al. Among authors: iagaru a. J Card Fail. 2019 Apr;25(4):307-311. doi: 10.1016/j.cardfail.2019.02.018. Epub 2019 Feb 27. J Card Fail. 2019. PMID: 30825644

10

Treatment of thyrotoxicosis.

Iagaru A, McDougall IR. Iagaru A, et al. J Nucl Med. 2007 Mar;48(3):379-89. J Nucl Med. 2007. PMID: 17332615 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters